The hormones estradiol, progesterone, testosterone, and DHEA can be compounded to meet your patient’s individual needs.  Hormones can be compounded as oral tablets, sublingual tablets, and creams, as well as other dosage forms.  We can combine multiple hormones in one dosage form.  Belmar can provide you with prescribing templates to ease the writing of compounded hormone prescriptions.  Belmar also compounds several medications used in vaginal health and sexual dysfunction.  

The term "Bio-Identical” means that the hormone has the same molecular structure as the hormone made by the human body (ovaries or adrenal gland), and is chemically and functionally the same.  Pharmacists prepare the compounded prescriptions from scratch using plant-derived natural ingredients from FDA approved sources.



SCHWARTZ, E., HOLTORF, K. and BROWNSTEIN, D. (2009). The Truth About Hormone Therapy .Printed in The Wall Street Journal, p.A17.

Schierbeck, L., Rejnmark, L., Tofteng, C., Stilgren, L., Eiken, P., Mosekilde, L., Kober, L. and Jensen, J. (2012). Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 345(9), pp.e6409-e6409.
Stephenson, K., Neuenschwander, P., Kurdowska, A., Pinson, B. and Price, C. (2008). Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women. Int J Pharm Compd., 12(4), pp.295-304. 
Klaiber, E., Vogel, W. and Rako, S. (2005). A critique of the Women’s Health Initiative hormone therapy study. Fertility and Sterility, 84(6), pp.1589-1601.
Chmouliovsky, L., Habicht, F., James, R., Lehmann, T., Campana, A. and Golay, A. (1999). Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas, 32(3), pp.147-153.
Ettinger, B., Friedman, G., Bush, T. and QusenberryJr, C. (1996). Reduced Mortality Associated With Long-Term Postmenopausal Estrogen Therapy. Obstetrics & Gynecology, 87(1), pp.6-12. 
Ruiz, A., Daniels, K., Barner, J., Carson, J. and Frei, C. (2011). Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study. BMC Women's Health, 11(1).

Wood, C., Sitruk-Ware, R., Tsong, Y., Register, T., Lees, C. and Cline, J. (2007). Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model. Menopause, 14(4), pp.639-647.
Colditz, G., Hankinson, S., Hunter D., Walter M., Manson, J., Stampfer, M., Hennekens, C., Rosner, B., and Speizer, F.(1995).  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. The Endocrinologist, 5(6), pp.441-442.

Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Berger, L., Gilbert, L., Martel, C. and Balser, J. (2011).  Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.  Climacteric, 14(2), pp.282-288. 
American Friends of Tel Aviv University. (2010, July 1). Increasing fertility threefold with DHEA?. ScienceDaily. Retrieved January 6, 2016 from
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J., Girard, G., Baron, M., Ayotte, N.,Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Berger, L., Gilbert, L., Martel, C. and Balser, J. (2009). Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause, 16(5), pp.923-931.
Jankowski, C., Gozansky, W., Kittelson, J., Van Pelt, R., Schwartz, R. and Kohrt, W. (2008). Increases in Bone Mineral Density in Response to Oral Dehydroepiandrosterone Replacement in Older Adults Appear to Be Mediated by Serum Estrogens. The Journal of Clinical Endocrinology & Metabolism, 93(12), pp.4767- 4773.
Barad, D. and Gleicher, N. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Human Reproduction, 21(11), pp.2845-2849.
Barad, D. and Gleicher, N. (2005). Increased oocyte production after treatment with dehydroepiandrosterone. Fertility and Sterility, 84(3), pp.756.e1-756.e3.
 Villareal, D. and Holloszy, J. (2004). Effect of DHEA on Abdominal Fat and Insulin Action in Elderly Women and Men. JAMA, 292(18), p.2243.
Oberbeck, R., Dahlweid, M., Koch, R., van Griensven, M., Emmendörfer, A., Tscherne, H. and Pape, H. (2001). Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Critical Care Medicine, 29(2), pp.380-384.
Barrett-Connor, E., von Mühlen, D., Laughlin, G. and Kripke, A. (1999). Endogenous Levels of Dehydroepiandrosterone Sulfate, but Not Other Sex Hormones, Are Associated with Depressed Mood in Older Women: The Rancho Bernardo Study. Journal of the American Geriatrics Society, 47(6), pp.685-691.
Wolkowitz, O., Reus, V., Keebler, A., Nelson, N. and Friedland, M. (1999). Double-Blind Treatment of Major  Depression with Dehydroepiandrosterone. The American Journal of Psychiatry, 156(4), pp.646-649.
Carson, P., Faquin, L. and Stentz, G. (1995). Replacement of dehydroepiandrosterone enhances T- lymphocyte insulin binding in postmenopausal women. Fertil Steril, 63(5), pp.1027-31.
Alzheimer's Disease 

 Espeland, M., Rapp, S., Shumaker, S., Brunner, R., Manson, J., Sherwin, B., Hsia, J., Margolis, K., Hogan, P., Wallace, R., Dailey, M., Freeman, R. and Hays. J. (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Womenʼs Health Initiative Memory Study. Jama, 291(24), pp. 2959-2968
Zandi, P., Carlson, M., Plassman, B., Welch-Bohmer, K., Mayer, L., Steffens, D. and Breitner, J. (2003). Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County StudyObstetrical & Gynecological Survey, 58(3), pp.186-188.
Cardiovascular Disease 
Nabel, E. (2000). Coronary Heart Disease in Women — An Ounce of Prevention. New England Journal of Medicine, 343(8), pp.572-574.
 Eye Disease
Anderson, G. (2017). Hormone Replacement Therapy May Protect Against Eye Disease. American Academy of Ophthalmology.


Belmar Pharmacy  800.525.9473  I  303.763.5533  I  231 Violet Street, Suite 140  I  Golden, CO 80401